CanSino Biologics Inc.
6185
H
(i)
2019 3 18 H H
H (ii) 2020
8 21 H (iii) 2020
9 21 H
H
H
1,309.8 1,122.3
H
H H
(1) 897.9 80%
(a) 505.1 45% MCV
(b) 224.5 20% DTcP
(c) 168.3 15%
1
(2) 112.2 10%
(3) 112.2 10%
2020 10 9 2020
H 682.8
MCV H
420.0 (i)
(ii) (iii)
2020 8 21 2020 9
21
2022 11 30 H 578.1
544.3
2022 12 2
DTcP H
100
H
H
2022 11 30 H H
2020
10 9
2022 H
11 30 H
H
H
H
MCV 38.2 – – –
DTcP 166.6 149.3 (100.0) 49.3 2024
2
2020
10 9
2022 H
11 30 H
H
H
H
41.8 10.7 – 10.7 2023
10.7 – – –
5.5 – – –
(i) 420.0 384.3 – 384.3 2023
(ii)
(iii)
– – 100.0 100.0 2024
682.8 544.3 100.0 544.3
H
COVID-19
H
H
3
H 2022 12 21
H
( www.cansinotech.com)
( www.hkexnews.hk) 2022 12 5
H
2022 12 20 2022 12 21
H H
H
2022 12 19 H
183 17 1712-
1716
Xuefeng YU
2022 12 2
Xuefeng YU Shou Bai CHAO
Dongxu QIU
4